Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Mhlstedt S, Ghadge SK, Duchene J, Qadri F, Jrve A, Vilianovich L, Popova E, Pohlmann A, Niendorf T, Boy P, zcelik C, Bader M
These findings suggest that GLP-1 receptor agonists may have kidney-protective effects in lupus nephritis, likely due to their anti-inflammatory properties
What they did: They transected the quadriceps (front thigh) of rats and divided them into three groups: Control, no drugs Dexamethasone, a potent corticosteroid that is known to impair healing Dexamethasone + BPC-157 What they found: Dexamethasone group: 50 % worse healing than control (confirmed negative effect of steroids) Dexamethasone + BPC-157 group: healing at the level of controls without steroids Why it matters: This is a highly clinically relevant finding
Coverage will continue only for employees who have been diagnosed with diabetes
